EUVIMEDEUVIMED entdecken
Open Access

The β2 adrenergic receptor cross-linked interactome identifies 14-3-3 proteins as regulating the availability of signaling-competent receptors

Ian B Chronis, Rachel Vistein, Avanti Gokhale, Victor Faundez, Manojkumar A Puthenveedu

Molecular Pharmacology · 2025

DOI: 10.1124/molpharm.124.000939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmacology, 2025. Verfasst von Ian B Chronis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Receptors, Adrenergic, beta-2, 14-3-3 Proteins, Signal Transduction. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIGMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emerging picture of G protein-coupled receptor function suggests that the global signaling response is an integrated sum of a multitude of individual receptor responses, each regulated by their local protein environment. The β2 adrenergic receptor (B2AR) has long served as an example receptor in the development of this model. However, the mechanism and the identity of the protein-protein interactions that govern the availability of receptors competent for signaling remain incompletely characterized. To address this question, we characterized the interactome of agonist-stimulated B2AR in human embryonic kidney 293 cells using FLAG coimmunoprecipitation coupled to stable isotope labeling by amino acids in cell culture and mass spectrometry. Our B2AR cross-linked interactome identified 190 high-confidence proteins, including almost all known interacting proteins and 6 out of 7 isoforms of the 14-3-3 family of scaffolding proteins. Inhibiting 14-3-3 proteins with the peptide difopein enhanced isoproterenol-stimulated adrenergic signaling via cAMP approximately 3-fold and increased both miniGs and arrestin recruitment to B2AR more than 2-fold each, without noticeably changing EC50 with respect to cAMP signaling or effector recruitment upon stimulation. Our results show that 14-3-3 proteins negatively regulate downstream signaling by inhibiting access of B2AR to effector proteins. We propose that 14-3-3 proteins maintain a dynamic pool of B2AR that has reduced signaling efficacy in response to acute agonist stimulation, limiting the number of signaling-competent receptors at the plasma membrane. SIGNIFICANCE STATEMENT: This study presents a new interactome of the agonist-stimulated β2 adrenergic receptor, a paradigmatic G protein-coupled receptor that is both a model system for members of this class and an important signaling protein in respiratory, cardiovascular, and metabolic regulation. We identify 14-3-3 proteins as responsible for restricting β2 adrenergic receptor access to signaling effectors and maintaining a receptor population that is insensitive to acute stimulation by agonists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Adrenergic, beta-214-3-3 ProteinsSignal TransductionHumansHEK293 CellsIsoproterenolCyclic AMPProtein Binding

Stichwörter der Autor:innen

Cell signalingG protein-coupled receptorProteomics

Substanzen

Receptors, Adrenergic, beta-214-3-3 ProteinsIsoproterenolCyclic AMP

Autor:innen und Institutionen

  • Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan.
  • Department of Molecular and Comparative Pathobiology, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Department of Cell Biology, Emory University School of Medicine, Atlanta, Georgia.
  • Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: puthenve@umich.edu.

Förderung

  • NIDA NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Chronis, I. B., Vistein, R., Gokhale, A., Faundez, V., & Puthenveedu, M. A. (2025). The β2 adrenergic receptor cross-linked interactome identifies 14-3-3 proteins as regulating the availability of signaling-competent receptors. Molecular Pharmacology. https://doi.org/10.1124/molpharm.124.000939

Vancouver

Chronis IB, Vistein R, Gokhale A, Faundez V, Puthenveedu MA. The β2 adrenergic receptor cross-linked interactome identifies 14-3-3 proteins as regulating the availability of signaling-competent receptors. Molecular Pharmacology. 2025. doi:10.1124/molpharm.124.000939

BibTeX
@article{Chronis2025,
  author = {Chronis, Ian B and Vistein, Rachel and Gokhale, Avanti and Faundez, Victor and Puthenveedu, Manojkumar A},
  title = {The β2 adrenergic receptor cross-linked interactome identifies 14-3-3 proteins as regulating the availability of signaling-competent receptors},
  journal = {Molecular Pharmacology},
  year = {2025},
  doi = {10.1124/molpharm.124.000939}
}
Kostenlos starten →